Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Author Guidelines

Journal Information and Submission Guidelines

The Janaki Medical College Journal of Medical Sciences (JMCJMS), bearing ISSN 2091-2242 (Print) and 2091-2358 (Online), is a peer-reviewed triannual biomedical journal that publishes original articles, review articles, case reports, letters to the editor, and book reviews. All submitted manuscripts undergo a rigorous peer-review process by subject experts prior to consideration for publication.

Submission of a manuscript implies that the work has not been previously published and is not under consideration by any other journal. Any form of duplicate submission or dual publication is considered a serious breach of publication ethics and will result in immediate rejection of the manuscript. Such violations may also lead to restrictions on future submissions from the concerned author(s).

All published articles, including their accompanying illustrations and materials, become the property of JMCJMS unless explicit rights are reserved prior to publication. The journal does not assume responsibility for the accuracy of data or statements made by the authors; all content and any false reporting remain the sole responsibility of the respective author(s).

Manuscripts must be prepared in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals,” developed by the International Committee of Medical Journal Editors (ICMJE). Submissions should be written in clear, concise, and grammatically correct English and addressed to the Editor-in-Chief/Executive Editor.

Submission Address

Editor-in-Chief / Executive Editor
Janaki Medical College Journal of Medical Sciences (JMCJMS)
Janaki Medical College
Ramdaiya, Janakpurdham, Nepal

Email: jmcjmsjanakimedicalcollege@gmail.com

Manuscript Submission Policy

JMCJMS accepts manuscript submissions via official email and/or the designated online submission system. Each submission must be accompanied by a covering letter clearly stating the manuscript title, full names of all authors, designation, institutional affiliations, valid email addresses of all authors, and complete details of the corresponding author. For studies involving human participants or animals, a valid ethical approval letter from the relevant Institutional Review Committee must be submitted at the time of manuscript submission. Manuscripts without ethical clearance, where applicable, will not be considered for review.

Upon successful receipt of the complete submission package, an acknowledgment email will be sent to the corresponding author. The completed author agreement form must also be submitted; digital signatures are acceptable. Only manuscripts fulfilling all submission requirements will proceed to editorial assessment and peer review. Submissions are accepted with the strict understanding that the manuscript is not under consideration elsewhere, has not been previously published, and is not submitted simultaneously to another journal.

Duplicate submission, redundant publication, or any form of publication misconduct will result in immediate rejection. The journal may also impose a ban on future submissions from the authors and notify the concerned institution for necessary investigation. JMCJMS reserves the right to take appropriate action against ethical violations, including retraction of published work and issuance of formal notices, in order to maintain scientific integrity and publication ethics.

Originality and Plagiarism Policy

JMCJMS maintains a strict policy on originality and academic integrity. All submitted manuscripts must be original and free from plagiarism in any form.

Plagiarism is defined as the use of another author’s published or unpublished ideas, data, text, images, or intellectual property without proper attribution, permission, or citation, and presenting them as original work. This applies to all formats, including print and electronic sources.

Authors are fully responsible for ensuring that their submitted work is original. Any use of previously published material must be properly cited and/or quoted according to standard scholarly practices. Proper citation alone does not justify excessive or inappropriate reproduction of content.

All manuscripts are subject to similarity checking during submission and review. If plagiarism is detected or suspected at any stage, the Editorial Board will initiate an investigation. Based on the severity of the misconduct, the manuscript may be rejected, corrected, or retracted.

Detection of plagiarism or any form of academic misconduct will result in immediate rejection of the manuscript and a minimum ban of three years on submission of any future manuscripts by the concerned author(s) to JMCJMS.

The journal also reserves the right to notify the authors’ affiliated institution and request a formal investigation. In serious cases, JMCJMS may publish notices or correspondence to maintain transparency and protect scientific integrity.

All authors, reviewers, and editors are expected to comply with  ethical standards of publication.  Any confirmed case of plagiarism or research misconduct may also be addressed in accordance with applicable institutional regulations, relevant national and international legal and ethical frameworks governing research integrity and scholarly publication.

Peer review Process

All manuscripts submitted to JMCJMS undergo an initial editorial screening to assess suitability, scientific quality, originality, ethical compliance, plagiarism, and adherence to the journal’s submission guidelines. The Editorial Office reserves the right to request additional documents, clarifications, or revisions from the authors before further processing. Manuscripts with plagiarism, ethical concerns, poor scientific quality, inadequate originality, major methodological flaws, or those outside the scope of JMCJMS will be rejected at the preliminary stage.

Manuscripts meeting the journal requirements are processed through a double-blind peer review system and are generally sent to at least two independent expert reviewers. The Editorial Board reserves the full right to select, invite, replace, or reject reviewers at any stage of the review process. Reviewers are required to disclose any conflict of interest and maintain strict confidentiality of the manuscript.

In-house submissions authored by Editors, Editorial Board members, or affiliated individuals are handled independently by editors with no conflict of interest to ensure impartiality and transparency in the review process.

Reviewers are normally requested to submit their review reports within the stipulated review period. However, delays may occur due to reviewer availability, withdrawal, or the need for additional expert opinions. The journal does not guarantee a fixed review timeline.

Based on reviewers’ comments, editorial assessment, scientific merit, and compliance with journal standards, the Editor-in-Chief/Executive Editor may decide to accept, reject, or request minor/major revisions of the manuscript. The decision of the Editorial Board shall be final.

Proof Correction and Pre-Publication Process

After acceptance, the corresponding author will receive an official acceptance notification from JMCJMS. Accepted manuscripts may undergo editorial editing, copyediting, formatting, and language correction to improve clarity, consistency, grammar, punctuation, and journal style without altering the scientific content or intended meaning of the manuscript.

Original articles and review articles are generally evaluated by at least two independent reviewers before final editorial decision. Following completion of editorial and production processes, the pre-publication PDF gallery proof (JMCJMS Author PDF proof) will be sent electronically to the corresponding author for final approval.

Authors are required to:

  • Carefully review the proof for typographical or minor corrections only;
  • Respond to all editorial queries;
  • Avoid major modifications, including changes in data, results, authorship, title, or scientific content at this stage; and
  • Return the corrected proof with final confirmation within 48 hours of receipt.

Failure to return the corrected proof or provide final approval within the stipulated time may result in delay, postponement, withdrawal, or cancellation of publication at the discretion of the Editorial Office. The final publication decision shall remain with the Executive Editor of JMCJMS.

Rejection Policy

Manuscripts that do not meet the scientific, ethical, or editorial standards of JMCJMS will be rejected in accordance with the journal’s publication policy. Grounds for rejection include, but are not limited to, poor scientific quality, lack of originality, ethical violations, plagiarism, policy non-compliance, or unfavorable recommendations from peer reviewers and/or editorial assessment. The final decision regarding rejection rests with the Editorial Board, with decision-making authority vested in the Editor-in-Chief/Executive Editor.

The corresponding author will be formally informed of the rejection decision. Where applicable, relevant reviewer comments may be shared to support transparency and guide future improvement.

Rejected manuscripts, along with submitted materials, will not be returned. Resubmission of manuscripts that have been substantially rejected may not be considered for further review at the discretion of the journal.

Appeal process

Authors may submit an appeal against a rejection decision by sending a formal written request to the Editorial Office of JMCJMS within the specified period after rejection notification. The appeal must clearly address the reviewer/editorial comments, provide scientific justification for reconsideration, and include point-by-point responses with supporting evidence where applicable.

Submission of an appeal does not guarantee reconsideration or acceptance. The Editor-in-Chief/Executive Editor reserves the full right to accept or reject the appeal and to decide whether the manuscript will undergo further editorial assessment or additional peer review. The decision of the journal shall be final and binding.

Complains

Complaints regarding scientific content, peer-review process, review bias, publication delay, authorship disputes, or publication ethics must be submitted to the Editorial Office of JMCJMS through official email communication with valid supporting evidence. The complaint must include the complainant’s full name, affiliation, and contact details. Anonymous, incomplete, defamatory, or unsupported complaints will not be entertained.

The Editor-in-Chief/Executive Editor will review the complaint and decide the appropriate course of action with discussion in Editorial Board.  The journal reserves the right to reject complaints lacking sufficient evidence and may take disciplinary action against misuse of the complaint process, including restriction of future submissions or communications with the journal.

Manuscript Withdrawal Policy

Authors are strongly encouraged to submit manuscripts only when they are fully prepared for publication consideration. Withdrawal of a manuscript after submission causes unnecessary use of editorial and peer-review resources; therefore, strict withdrawal regulations are applied.

  1. Withdrawal Before Peer Review

Authors may request withdrawal of a manuscript before the peer-review process begins by submitting a formal written request signed by the corresponding author, clearly stating the reason for withdrawal.

  1. Withdrawal During Peer Review

Once the manuscript has entered the peer-review process, withdrawal requests will be considered only under exceptional circumstances. A detailed justification must be provided by the authors. The Editorial Board reserves the right to approve or reject the request.

  1. Withdrawal After Acceptance

Withdrawal of a manuscript after editorial acceptance is strongly discouraged and will generally not be permitted except in cases involving serious scientific errors, ethical concerns, or other unavoidable circumstances supported by valid evidence.

  1. Unauthorized Withdrawal

Failure to respond to editorial communications or submitting the same manuscript to another journal without obtaining formal withdrawal approval from the journal will be considered unethical publication practice.

  1. Penalty for Unethical Withdrawal

In cases of unethical or unjustified withdrawal, the journal reserves the right to impose one or more of the following penalties:

  • Temporary restriction on new submissions from the authors for a period of 1–3 years;
  • Blacklisting of the authors from future publication consideration in the journal;
  • Notification to the authors’ affiliated institution, department, or funding agency if deemed necessary;
  • Rejection of any other manuscripts currently under consideration by the same authors; and
  • Publication of a notice regarding unethical withdrawal if serious misconduct is identified.
  1. Withdrawal Procedure

All withdrawal requests must:

  • Be submitted through official email communication;
  • Include manuscript title, manuscript ID, and detailed reason for withdrawal; and
  • Be approved by all co-authors.

A manuscript will be considered officially withdrawn only after written confirmation is issued by the Editorial Office.

Authorship Criteria

 An ‘author’ is someone who has made substantive intellectual contributions to a study.
In accordance with ICMJE guidelines (www.icmje.org), authorship credit requires all the following conditions to be met.

All authors whose names appear on the submission

  1. made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;
  2. drafted the work or revised it critically for important intellectual content;
  3. approved the version to be published; and
  4. agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All authors should have participated sufficiently in the work to take public responsibility for the content. All authors must sign an undertaking accepting responsibility for the submitted manuscript. Authors are required to state their exact contribution to the study; the Journal may print this information. The order of authorship should be decided by all the authors. The journal strongly discourages alterations in the sequence or deletion/addition of authors at any time after submission of the manuscript.

Affiliation

Each author's principal affiliation should to be the organization where the majority of their work was completed. It may also provide the author's current address if they have since moved. After the article is published, addresses won't be updated or modified.

Role of the Corresponding Author

As the Corresponding Author, one author represents all of the authors and makes sure that any concerns about the accuracy or integrity of any component of the work are duly addressed. They also handle all correspondence between the Journal and the co-authors, both before and after publication. A Contact or Submitting Author may be assigned the responsibility of overseeing all correspondence between the journal and each co-author during the submission and proofing stage. In this instance, please make sure the Corresponding Author is clearly indicated in the manuscript.

Changes to Authorship

Authors are strongly advised that authors ensure that the author group, corresponding author, and author order are correct at the time of submission. All authors must consent to any modifications made to the list of authors after it has been submitted, including rearranging the authors' order or adding or removing authors. After a submission is accepted, changes to the authorship including adding or removing authors, altering the corresponding author, or changing the order in which authors appear are not allowed. At the revision stage, adding or removing authors is usually not allowed, though there are several circumstances in which it might be justified. The editorial office should be notified right away of the explanations and changes in authorship for these modifications. The decision to approve the modification during revision remains with the Editor-in-chief/Executive Editor.

Disclosures and declarations

Public health and general welfare may be affected by work submitted for publication; in such circumstances, it is the duty of all authors to provide the necessary disclosures and declarations. Information about funding sources, financial and non-financial interests, study-specific approval by the relevant ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and, if appropriate, a statement on animal welfare are all requested to be included by all authors.

Author Identification Policy

Janaki Medical College Journal of Medical Sciences (JMCJMS) strongly encourages all authors to provide a valid ORCID iD during manuscript submission. ORCID provides a unique and persistent digital identifier that ensures accurate author identification, enhances transparency, and supports international standards of scholarly communication.

Authors are also required to provide their full name, institutional affiliation, and an official institutional email address wherever available. The use of personal email addresses is permitted; however, institutional email addresses are preferred to ensure authenticity and traceability.

Author identification details must be accurate and consistent with international authorship standards to avoid ambiguity and ensure proper attribution of scholarly work. The journal follows globally accepted best practices for author identification and metadata standardization in accordance with modern publishing guidelines.

Author Contribution Statement

For all submitted manuscripts, including original research, review articles, case reports, and other article types, authors must provide a clear Author Contribution Statement. This statement should specify the individual contributions of each author to the conception, design, data acquisition, analysis, interpretation, drafting, critical revision, and final approval of the manuscript.

Authorship credit should be based on substantial contributions in accordance with internationally accepted authorship criteria (e.g., ICMJE guidelines). All listed authors must take public responsibility for the content and agree to be accountable for all aspects of the work.

The contribution statement must be included in the manuscript at the time of submission and will be published alongside the article if accepted.

Authorship disputes

JMCJMS follows internationally recognized publication ethics standards, including COPE and ICMJE guidelines, and applies a strict institutional ethics-based approach to authorship integrity.

In the event of an authorship dispute arising at any stage of manuscript processing (submission, peer review, acceptance, or post-publication), the journal will not act as an arbitrator or adjudicator of authorship claims. Responsibility for resolving such disputes rests primarily with the authors and their respective institutions, in line with international best practices.

All authors are expected to have agreed on authorship order, contributions, and responsibilities prior to submission. Any disputes regarding authorship must be resolved at the institutional level in accordance with applicable national research governance frameworks, including guidance from the Nepal Health Research Council (NHRC), Nepal and relevant institutional ethics committees.

If authors fail to resolve the dispute, JMCJMS reserves the right to:

  • Suspend or withdraw the manuscript from editorial or peer-review processing; and/or
  • In the case of a published article, issue corrections, expressions of concern, or retractions as appropriate.

Where necessary, the journal may refer the matter to the authors’ affiliated institution(s) for formal investigation and will act in accordance with the institution’s findings and applicable international publication ethics standards.

Types of manuscript and word limits

Original Article:

Original articles should not exceed 5000 words. It should not exceed 24 pages double-spaced typewritten pages, including tables, figures and references.  The references should be limited to 30.  Abstracts should not exceed 300 words.  Manuscripts submitted as original articles that exceed these limits will be returned without review at the discretion of the editorial board. Original Articles should have following headings in its manuscript:

Title, Abstract, Key Words, Introduction, Methodology, Results, Discussion, Conclusion, Acknowledgement (Not always), References

Title: Title should be short and give an impression of the paper. It should not exceed 30 words.

Abstracts: The abstract should contain the essence of the whole paper and should stand-alone. It should be concise and clear. Please be sure on following points while preparing Abstract of the article:

  • Word limits – 300 words
  • No abbreviation to be used in abstract
  • Structured abstract - into following sub groups:
    • Background and Objectives , Methodology, Results, Conclusion

Key Words

Key Words – 3-7 words, arranged in alphabetical order. These words should the follow MeSH list.

Introduction

Provide the context or background of the study. State the purpose or the research objectives of the paper clearly. Do not review the subject extensively and give only pertinent references.

Materials and Methods

The materials and methods section should only include information that was available at the time that the study was planned or the protocol written.  All information obtained during the conduct of the study should be written in the results section.

Selection and Description of Participants

Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population.  Because the relevance of such variables as age and sex to the object of research is not always clear, authors should explain their use when they are included in a study report. For example, authors should explain why only subjects of certain ages were included or why women were excluded. The guiding principle should be clarity about how and why a study was done in a particular way. When authors use variables such as race or ethnicity, they should define how they measured the variables and justify their relevance.

Technical information

Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods.  Provide references and brief descriptions for methods that have been published but are not well known. Describe new or substantially modified methods, give reasons for using them and evaluate their limitations. Precisely identify all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

Ethical issues

Janaki Medical College Journal of Medical Sciences (JMCJMS) is committed to upholding the highest standards of research, editorial, and publication ethics, and follows international guidelines, procedures, and policies (e.g. Committee of Publication Ethics [COPE], and Office of Research Integrity [ORI]) when dealing with any cases of suspected ethical misconduct. If such cases arise, the journal may share relevant information with necessary third parties (for example, authors’ institutes). All information will be treated in a confidential, factual, and non-judgmental manner. JMCJMS also retain the right to pursue any issues of ethical misconduct even after rejection or withdrawal of a manuscript from the journal. Evidence of approval by a local Ethics Committee (for both human and animal) must be supplied during submission of manuscripts.

Statistics

Describe statistical methods with enough detail to enable a reader with access to the original data to verify the reported result. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as P values. These fail to convey important information such as the effect of the size of the population. References for the design of the study and statistical methods should be to standard procedures when possible. Define statistical terms, abbreviations, and symbols. Specify the computer software used.

Results

Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat all the data of the tables or the illustrations in the text.  When data are summarized in the Results section, give numeric results not only as derivatives (for example percentage), but also the absolute numbers from which the derivatives were calculated. Specify the statistical methods that were used to analyse them. Restrict tables and figures to those needed to explain the argument of the paper and to assess the supporting data. Use graphs as an alternative to tables that require many entries.  Do not duplicate data in graphs and tables.  Avoid non-technical uses of technical terms in statistics, such as “random” (which implies randomizing device), “normal”, “significant”, “correlations” and “sample”. Where scientifically appropriate, analysis of the data by such variables as age and sex should be included.

Discussion

Emphasize the new and important aspects of the study and the conclusions that follow from them.  Do not repeat in detail the data or other information given in the Introduction or the Results section. For experimental studies, it is useful to begin the discussion by briefly summarizing the main findings. Compare and contrast the results with the study, and explore the implications of the findings for future research and for clinical practice.

Conclusion
Link the conclusions with the goals of the study but avoid unqualified statements and conclusions that are not adequately supported by the data. You can provide the future implications, future direction and limitation of the study too. As other journal, conclusion can also be included in last paragraph of Discussion section.

Acknowledgments
Acknowledgement should state the person(s)/firms that the author is required to acknowledge.

References

The Vancouver system of referencing should be used.  Authors are responsible for the accuracy of each reference and checking them against the original article.  Provide a list of references, double-spaced, after the text.  Cite references in the text using [ ] bracket and Arabic numerals in the order in which they appear in the text.  Abbreviate titles of journals according to MEDLINE.

Like: text [1, 2, 3].

Examples:

  1. Chia RY, Hughes RS, Morgan MK. Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2002; 9:279-81. [upto six authors]
  2. Stippler M, Crago E, Levy EI et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg 2006; 105:723-9. [for more than six authors, mention first 3 authors followed by et al.]

For Book

Author(s) – Family name and initials, editor. Title of Book. Volume. Publisher: Where published; year published. page(s)

Smith JB, editor. Pathology of the lung. Vol 18 3rd ed. John Green Co: Montreal; 1970. 179pp.

Chapter in a Book

Author(s) – Family name and initials. Title of Chapter, In: Title of Book. Publisher: Where published; year published. page(s).

Brown AB, Green XY.  Jejunal pathology, In: Black CD, White EF, (eds). Gastrointestinal pathology; an introduction. 2nd edn. Raven: New York; 1995. pp 465-469.

For Electronic citations

Author. Title of publication [type of medium – Internet]. Place of publication (if available): Publisher (if available); Date of publication – year month day (supply year if month and day not available) [updated year month day; cited year month day]. Available from: web address.

Clea Japan [homepage on the Internet]. Osaka: Clea Japan, c1999-2004. (Cited 25 November 2004) Inbred animals. Available from: http://www.clea-japan.co.jp/animals/b6-3.htm.

Abbreviations and Symbols

Use only standard abbreviations.  Please refer to Proc Natl Acad Sci USA, 92: vii-x (1995) for guidance as to which abbreviations are considered standard. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. Do not use abbreviations like @ or & in the text.

Legends

Put tables, charts, and figures at the end of the paper, after references

Use Legends as: Table e.g. (Table 1) and Figure e.g. (Figure 3).

Review Article:  Review articles should not exceed 6000 words and 35 double-spaced typewritten pages, including tables, figures and references.  The number of references should be limited to 50 (if more than that, justification needed). It should contain abstract, Introduction, Main body text (with headings and subheadings as required), conclusion and future direction.

Theoretical Research article: It should not exceed 6000 words and 35 double-spaced typewritten pages, including tables, figures and references. The number of references should be limited to 50 (if more than that, justification needed). It should contain abstract, Introduction, Main body text (with headings and subheadings as required), conclusion and future direction. Conclusion and future direction is mandatory in such article.

Case report:  Case reports must provide new information. Clinically significant observations based on new or developing technology will receive special consideration. Brevity is required.  Case studies must not be more than 2500 words 10 double spaced typed pages, including tables, figures and references.  The number of references should be 15 or less and the number of figures should be 3 or less. Justify if more is most. Abstracts should not exceed 200 words. It should contain: (Background and objectives; Presentation of case; Discussion; Conclusion; Keywords).  Manuscripts submitted as case studies that do not conform to these requirements will be returned without review.

Letters to the editor: Letters to the editor should contain a brief abstract that is short and decisive. They should not be preliminary observations that require a paper for later validation. They should not be more than 500 words and be limited to 5 references.

Limits for the number of images and tables:  For all the above mentioned categories the number of images and tables should not be more than one per 500 words.

Training Report: The section includes workshop, training and event report (2500-3000 words) which are relevant with medicine, research and health related field. It should consist background, objectives, schedule of the program, major highlights and photographs, acknowledgements and appendices (references should not exceed more than 5).

Medical Education: This section article includes less than 3,000 words plus a structured abstract of no more than 300 words. References should not exceed 25 and up to two tables or figures are permissible. Authors are notified that Medical Education section papers are aimed at particularly with contemporary affairs in Medical Education, new discoveries, and policies that stand up to scientific scrutiny. Manuscripts must offer a compelling and scholarly indication that will help advance educational practice and/or research.

Medical ethics: Articles (approx. 2000-2500 words) dealing with ethical aspects of practice of medicine or medical research. Legal issues in medicine can also be highlighted in this section.  Reference should not exceed more than 15 (if more justification needed).

Medical Humanities: These articles (2500-3000 words) must engage with current scholarship which may have important social, economic or political dimensions shaping the conversation around medicine as practice and philosophy as it engages with humanities and arts, social sciences, health policy, medical education, patient experience and the public at large. The critical and scholarly submissions of interest in this section include epidemics and disease, history of medicine, cultures of medicine, disability studies, gender and the body, communities in crisis, bioethics, and public health interlinked with social science and humanities and its impact on society. Unstructured abstract limited within 200 words and references should not exceed more than 20.

Obituaries: A doctor/ research scientist working in Nepal or working abroad had died and  left her/his mark on society or on the profession in the field of medicine and scientific research community and whose contributions need to be highlighted. A brief sketch of the person’s personal and professional life along with a photograph may be submitted (approx. 1200 words; Reference should not exceed more than 5).

Short Communications: These articles (1500-2000 words) are a concise communication which includes a forum to address new issues which are relevant to the readership in the field of medicine and medical sciences.  The article should be structured (Introduction, objectives, materials and methods, result, conclusion). Figures and Short tables should not be more than 3.  No abstract is required. The editorial team reserves the right to decide which tables/figures submitted are necessary.

Perspectives: These articles (3500-4000 words) offer the author the opportunity to present any novel ideas and criticism in the field of medicine and health sciences. Authors of perspectives are encouraged to be highly opinionated and should represent a personal perspective which should be scientific, logical addressing controversies with intellectual content. An expert opinion subtitle (minimum 700 words) is mandatory before the reference section. This article should have structured abstract. Reference should be limited within 30. The editors are highly preferred however potential authors are also encouraged.

Innovations Corner: These articles (1500-2400 words) include health systems and processes interventions and innovations, emphasizing the process, keys to success, and what others can learn from your work. Key to innovations should be summarized in 3-5 bullet points at last how this innovation can be adopted by another institution or become a multisite collaboration. We particularly welcome submissions that address common challenges for patients, care teams, and institutions in the field of medicine.  The article should have 100–150-word unstructured abstract.  Maximum 2 tables or figure and references no more than 8.

Book Review: Book reviews are an opportunity to explore one or more books on a topic in a well-defined, but necessarily limited way. Any book review health related medical education/policy book in the field of medicine and medical sciences should be limited within 1500 words with minimum two photographs highlighting the introduction of the book, striking contents, major arguments and discussion, positive and negative critics, publisher details with cover page.

Opinion/Viewpoints : These articles (1500-2800 words) allow authors to present a particular perspective on a topic of current interest and challenges in the field of medicine,  healthcare, public health, research, discovery, prevention, ethics, health policy, or health law and generally are not linked to a specific article. Opinion articles should be backed up by a solid grounding in the published literature and are not intended for largely speculative or hypothetical discussions. The article should be clear, compelling, well argued with new insights and appeal to our international readership in health sciences and medicine community. Viewpoints must have no more than 3 authors. The first author should have sufficient expertise and experience with the topic to provide an authoritative opinion. The article should be presented with 1 small table or figure and up to 8 references (where appropriate), which should be as current as possible. Reference should not exceed 15. Unstructured abstract (200 Words) if required with decision of editorial board.   Viewpoints not meeting these guidelines will not be considered.

Commentary: Commentaries (1200 words) discusses a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field. Commentaries can also generally address unresolved and timely issues in health and medicine, and should provide sufficient evidence to support the authors' views. Maximum 2 tables/figures are limited and references should not exceed 20. No abstract is required.

All types of Manuscript should have title page and the title page should contain:

  1. Type of manuscript (e.g. Original article, Case report, Review Article etc.)
  2. The title of the article, which should be concise, but informative;
  3. Running title or short title not more than 50 characters;
  4. The name by which the author is known (Last name, First name and Middle name)
  5. The name of the department and institution to which the work should be attributed.
  6. The name, address, phone number, fax-number. email address of the contributors for correspondence about the manuscript;
  7. Source(s) of support in the form of grants, equipment, drugs, or all of these;

Authors name should not be present on other pages than title page

 

 

Training Report

 

 

 

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 4 November 2025)